| Product Code: ETC7660084 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Primary Biliary Cholangitis Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Primary Biliary Cholangitis Market - Industry Life Cycle |
3.4 Israel Primary Biliary Cholangitis Market - Porter's Five Forces |
3.5 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Primary Biliary Cholangitis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Primary Biliary Cholangitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of primary biliary cholangitis in Israel |
4.2.2 Rising awareness about early diagnosis and treatment options |
4.2.3 Technological advancements in diagnostic tools and treatment modalities |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Limited availability of specialized healthcare professionals |
4.3.3 High treatment costs for primary biliary cholangitis therapies |
5 Israel Primary Biliary Cholangitis Market Trends |
6 Israel Primary Biliary Cholangitis Market, By Types |
6.1 Israel Primary Biliary Cholangitis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Liver Transplantation, 2021- 2031F |
6.1.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Drug Therapy, 2021- 2031F |
6.1.5 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Ursodeoxycholic acid (UDCA), 2021- 2031F |
6.1.6 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Obeticholic acid, 2021- 2031F |
6.1.7 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Fibrates, 2021- 2031F |
6.1.8 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Budesonide, 2021- 2031F |
6.2 Israel Primary Biliary Cholangitis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By FibroScan, 2021- 2031F |
6.2.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.2.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Cholesterol Test, 2021- 2031F |
6.2.5 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Antibody Test, 2021- 2031F |
6.2.6 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Liver Test, 2021- 2031F |
6.2.7 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Primary Biliary Cholangitis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Primary Biliary Cholangitis Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Primary Biliary Cholangitis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 Israel Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Primary Biliary Cholangitis Market Import-Export Trade Statistics |
7.1 Israel Primary Biliary Cholangitis Market Export to Major Countries |
7.2 Israel Primary Biliary Cholangitis Market Imports from Major Countries |
8 Israel Primary Biliary Cholangitis Market Key Performance Indicators |
8.1 Average time to diagnosis for primary biliary cholangitis patients |
8.2 Adoption rate of novel treatment options in the market |
8.3 Number of clinical trials focused on primary biliary cholangitis treatments |
8.4 Patient adherence rate to prescribed treatment regimens |
8.5 Rate of hospital readmissions for primary biliary cholangitis patients |
9 Israel Primary Biliary Cholangitis Market - Opportunity Assessment |
9.1 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Primary Biliary Cholangitis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Primary Biliary Cholangitis Market - Competitive Landscape |
10.1 Israel Primary Biliary Cholangitis Market Revenue Share, By Companies, 2024 |
10.2 Israel Primary Biliary Cholangitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here